'Bazinc' instinct: How SEA attracts MCH class II molecules

Research in Immunology

Volumn 148, Issue 4, 1997, Pages 217-229

  Thibodeau, J ^a   Lavoie, P M ^b,c   Cazenave, P A ^a  

^a INSTITUT PASTEUR   (France)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REVIEW; SEQUENCE ANALYSIS; STOICHIOMETRY; T LYMPHOCYTE ACTIVATION;

EID: 0030763279     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(97)80864-4     Document Type: Article

References (72)

1. Abrahmsen, L., Dohlsten, M., Segren, S., Bjork, P., Jonsson, E. & Kalland, T. (1995), Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J. 14, 2978-2986.
2. Acharya, K.R., Passalacqua, E.F., Jones, E.Y., Harlos, K., Stuart, D.I., Brehm, R.D. & Tranter, H.S. (1994), Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature (Lond.), 367, 94-97.
3. Alcover, A., Juillard, V. & Acuto, O. (1992), Engagement of major histocompatibility complex class I and II molecules up-regulates intercellular adhesion of human B cells via a CD11/CD18-independent mechanism. Eur. J. Immunol., 22, 405-412.
4. Altomonte, M., Pucillo, C., Damante, G. & Maio, M. (1993), Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY. J. Immunol., 151, 5115-5122.
5. Antonsson, P., Gjörloff Wingren, A., Hansson, J., Kalland, T., Varga, M. & Dohlsten, M. (1997), Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR. J. Immunol., 158, 4245-4251.
6. Aoudjit, F., Al-Daccak, R., Léveillé, C. & Mourad, W. (1995), Effects and mechanisms underlying the interaction of bacterial superantigens with MHC class II-positive cells, in "Bacterial superantigens: structure, function and therapeutic potential". (Thibodeau, J. and Sékaly, R.P.) (pp. 147-160).
7. Bergdoll, M.S. (1985), The staphylococcal enterotoxins - an update, in "The staphylococci", J. Jeljaszewicz (Ed.) (pp. 247-54) Verlag, New York.
8. Bonnefoy, J.-Y., Guillot, O., Spits, H., Blanchard, D., Ishizaka, K. & Banchereau, J. (1988), The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens. J. Exp. Med., 167, 57-72.
9. Brown, J.H., Jardetzky, T., Saper, M.A., Samraoui, B., Bjorkman, P.J. & Wiley, D.C. (1988), A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (Lond.), 332, 845-850.
10. Chatila, T. & Geha, R.S. (1993), Signal transduction by microbial superantigens via MHC class II molecules. Immunol. Rev., 131, 43-59.
11. Choi, Y., Herman, A., DiGuisto, D., Wade, T., Marrack, P. & Kappler, J.W. (1990), Residues of the variable region of the T cell receptor β-chain that interact with S. aureus toxin superantigens. Nature (Lond.), 346, 471-473.
12. Deckhut, A.M., Chien, Y.-H., Blackman, M.A. & Woodland, D.L. (1994), Evidence for a functional interaction between the β chain of major histocompatibility complex class II and the T cell receptor α chain during recognition of a bacterial superantigen. J. Exp. Med., 180. 1931-1935.
13. Dellabona, P., Peccoud, J., Kappler, J., Marrack, P., Benoist, C. & Mathis, D. (1990), Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62, 1115-1121.
14. Ehrich, E.W., Devau, B., Rock, E.P., Jorgensen, J.L., Davis, M.M., Chien, Y.-H. & Chien, Y.H. (1993), T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J. Exp. Med., 178, 713-722.
15. Fields, B.A., Malchiodi, E.L., Li, H.M., Ysern, X., Stauffacher, C.V., Schlievert, P.M., Karjalainen, K. & Mariuzza, R.A. (1996), Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (Lond.), 384, 188-192.
16. Fraser, J.D., Urban, R.G., Strominger, J.L. & Robinson, H. (1992), Zinc regulates the function of two superantigens. Proc. Natl. Acad. Sci. USA, 89, 5507-5511.
17. Friedman, S.M., Posnett, D.N., Tumang, J.R., Cole, B.C. & Crow, M.K. (1991), A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis. Rheum., 34, 468-479.
18. Harris, T.O., Grossman, D., Kappler, J.W., Marrack, P., Rich, R.R. & Betley, M.J. (1993), Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect. Immun., 61, 3175-3183.
19. Hauschildt, S., Bessler, W.O. & Scheipers, P. (1993), Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow-derived macrophages. Eur. J. Immunol., 23, 2988-2992.
20. Heidelberger, M. & Kendall, F.E. (1935), The precipiting reaction between type III penumococcus polysaccharide and homologous antibody. J. Exp. Med., 62, 563-591.
21. Herman, A., Croteau, G., Sekaly, R.-P., Kappler, J. & Marrack, P. (1990), HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J. Exp. Med., 172, 709-717.
22. Herman, A., Labrecque, N., Thibodeau, J., Marrack, P., Kappler, J.W. & Sekaly, R.-P. (1991), Identification of the staphylococcal enterotoxin A superantigen binding site in the β1 domain of the human histocompatibility antigen HLA-DR. Proc. Natl. Acad. Sci. USA, 88, 9954-9958.
23. Herrmann, T., Accolla, R.S. & MacDonald, H.R. (1989), Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes. Eur. J. Immunol., 19, 2171-2174.
24. Hudson, K.R., Tiedemann, R.E., Urban, R.G., Lowe, S.C., Strominger, J.L. & Fraser, J.D. (1995), Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J. Exp. Med., 182, 711-720.
25. Ignatowicz, L., Winslow, G., Bill, J., Kappler, J. & Marrack, P. (1995), Cell surface expression of class II MHC proteins bound by a single peptide. J. Immunol., 154, 3852-3862.
26. Ikejima, T., Dinarello, C.A., Gill, D.M. & Wolff, S.M. (1984), Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J. Clin. Invest., 73, 1312-1320.
27. Irwin, M.J., Hudson, K.R., Fraser, J.D. & Gascoigne, N.R.J. (1992), Enterotoxin residues determining T-cell receptor Vβ binding specificity. Nature (Lond.), 359, 841-843.
28. Jardetzky, T.S., Brown, J.H., Gorga, J.C., Stern, L.J., Urban, R.G., Chi, Y.-I., Stauffacher, C., Strominger, J.L. & Wiley, D.C. (1994), Three-dimensional structure of human class II histocompatibility molecule complexed with superantigen. Nature (Lond.), 368, 711-718.
29. Karp, D.R., Dowd, J.E. & Karr, R.W. (1995), Functional activity of staphylococcal enterotoxin A requires interactions with both the alpha and beta chains of HLA-DR, in "9th International Congress of Immunology". [Abstract].
30. Karp, D.R. & Long, E.O. (1992), Identification of HLA-DR1 β chain residues critical for binding staphylococcal enterotoxins A and E. J. Exp. Med., 175, 415-424.
31. Kim, J., Urban, R.G., Strominger, J.L. & Wiley, D.C. (1994), Crystallographic structure of toxic shock syndrome toxin-1 complexed with a human class II major histocompatibility molecule HLA-DR1. Science, 266, 1870-1874.
32. Kotzin, B.L., Leung, D.Y.M., Kappler, J. & Marrack, P. (1993), Superantigens and their potential role in human disease. Adv. Immunol., 54, 99-166.
33. Kozono, H., Parker, D., White, J., Marrack, P. & Kappler, J. (1995), Multiple binding sites for bacterial superantigens on soluble class II major histocompatibility complex molecules. Immunity 3, 187-196.
34. Kozono, H., White, J., Clements, J., Marrack, P. & Kappler, J.W. (1994), Production of soluble MHC class II proteins with covalently bound single peptides. Nature (Lond.), 369, 151-154.
35. Labrecque, N., Thibodeau, J., Mourad, W. & Sekaly, R.-P. (1994), T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. J. Exp. Med., 180. 1921-1929.
36. Labrecque, N., Thibodeau, J. & Sekaly, R.-P. (1993), Interactions between staphylococcal superantigens and MHC class II molecules. Semin. Immunol., 5. 23-32.
37. Lavoie, P.M., Thibodeau, J., Cloutier, I., Busch, R. & Sekaly, R.P. (1997), Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM. Proc. Natl. Acad. Sci. USA, 94, 6892-6897.
38. Marrack, P., Blackman, M., Kushnir, E. & Kappler, J. (1990), The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med., 171, 455-464.
39. Marrack, P. & Kappler, J. (1990), The staphylococcal enterotoxins and their relatives. Science 248, 705-711.
40. Mehindate, K., Al-Daccak, R., Damdoumi, F. & Mourad, W. (1996), Synergistic effect between CD40 and class II signals overcomes the requirement for class II dimerization in superantigen-induced cytokine gene expression. Eur. J. Immunol., 26, 2075-2080.
41. Mehindate, K., Thibodeau, J., Dohlsten, M., Kalland, T., Sekaly, R.-P. & Mourad, W. (1995), Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J. Exp. Med., 182, 1573-1577.
42. Micusan, V.V. & Thibodeau, J. (1993), Superantigens of microbial origin. Semin. Immunol., 5, 3-11.
43. Mollick, J.A., Chintagumpala, M., Cook, R.G. & Rich, R.R. (1991), Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J. Immunol., 146, 463-468.
44. Mourad, W., Geha, R.S. & Chatila, T. (1990), Engagement of major histocompatibility complex class II molecules induces sustained, LFA-1 dependent cell adhesion. J. Exp. Med., 172, 1513-1516.
45. Mourad, W., Mehindate, K., Schall, T.J. & McColl, S.R. (1992), Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J. Exp. Med., 175, 613-616.
46. Nabavi, N., Freeman, G.J., Gault, A., Godfrey, D., Nadler, L.M. & Glimcher, L.H. (1992), Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (Lond.), 360, 266-268.
47. Newton, D.W., Dohlsten, M., Olsson, C., Segren, S., Lundin, K.E.A., Lando, P.A., Kalland, T. & Kotb, M. (1996), Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vβ specificity. J. Immunol., 157, 3988-3994.
48. 2 from Staphylococcus aureus reveals a zinc-binding site. Structure, 3, 769-779.
49. Parsonnet, J. & Gillis, Z.A. (1988), Production of tumor necrosis factor by human monocytes in response to toxic shock syndrome toxin-1. J. Infect. Dis., 158, 1026-1033.
50. Parsonnet, J., Gillis, Z.A. & Pier, G.B. (1986), Induction of interleukin-1 by strains of Staphylococcus aureus from patients from non-menstrual toxic shock syndrome. J. Infect. Dis., 154, 55-63.
51. Prasad, G.S., Earhart, C.A., Murray, D.L., Novick, R.P., Schlievert, P.M., Ohlendorf, D.H. (1993), Structure of toxic shock syndrome toxin I. Biochemistry, 32, 13761-13766.
52. β region (65-85) is a binding site for the superantigen, staphylococcal enterotoxin. A. Biochem. Biophys. Res. Commun., 168, 696-701.
53. Russell, J.K., Pontzer, C.H. & Johnson, H.M. (1991), Both α-helices along the major histocompatibility complex binding cleft are required for staphylococcal enterotoxin A function. Proc. Natl. Acad. Sci. USA, 88, 7228-7232.
54. Schad, E.M., Zaitseva, I., Zaitsev, V.N., Dohlsten, M., Kalland, T., Schlievert, P.M., Ohlendorf, D.H. & Svensson, L.A. (1995), Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J., 14, 3292-3301.
55. Scherer, M.T., Ignatowicz, L., Winslow, G.M., Kappler, J.W. & Marrack, P. (1993), Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell. Biol., 9, 101-128.
56. Schick, M.R. & Levy, S. (1993), The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules. J. Immunol., 151, 4090-4097.
57. Scholl, P.R. & Geha, R.S. (1994), MHC class II signaling in B-cell activation. Immunol. Today, 15, 418-422.
58. Spertini, F., Spits, H. & Geha, R.S. (1991), Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci USA 88, 7533-7537.
59. 2+-mediated homodimerization. EMBO J., 15, 6832-3840.
60. 2+ at 2.7 angstrom resolution - implications for major histocompatibility complex class II binding. J. Biol. Chem., 271, 32212-32216.
61. Surman, S., Deckhut, A.M., Blackman, M.A. & Woodland, D.L. (1994), MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. J. Immunol., 152, 4893-4902.
62. Swaminathan, S., Furey, W., Pletcher, J. & Sax, M. (1992), Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature (Lond.), 359, 801-806.
63. Taub, D.D., Newcomb, J.R. & Rogers, T.J. (1992), Effect of isotypic and allotypic variations of MHC class II molecules on staphylococcal enterotoxin presentation to murine T cells. Cell. Immunol., 141, 263-278.
64. Thibodeau, J., Cloutier, I., Lavoie, P.M., Labrecque, N., Mourad, W., Jardetzky, T. & Sekaly, R.-P. (1994), Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science, 266, 1874-1878.
65. Thibodeau, J., Dohlsten, M., Cloutier, I., Lavoie, P.M., Bjork, P., Michel, F., Léveillé, C., Mourad, M., Kalland, T. & Sékaly, R.P. (1997), Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DRα chain. J. Immunol., 158, 3698-3704.
66. Tiedemann, R.E. & Fraser, J.D. (1996), Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. J. Immunol., 157, 3958-3966.
67. 2 trimers in solution. Proc. Natl. Acad. Sci. USA, 92, 12156-12159.
68. Trede, N.S., Geha R.S. & Chatila, T. (1991), Transcriptional activation of IL-1β and tumor necrosis factor-a genes by MHC class II ligands. J. Immunol., 146, 2310-2315.
69. Ulrich, R.G., Bavari, S. & Olson, M.A. (1995), Staphylo coccal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules. Nature Struct. Biol., 2, 554-560.
70. Von Bonin, A., Ehrlich, S., Malcherek, G. & Fleischer, B. (1995), Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. Eur. J. Immunol., 25, 2894-2898.
71. Wen, R., Broussard, D.R., Surman, S., Hogg, T.L., Blackman, M.A. & Woodland, D.L. (1997), Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Eur. J. Immunol., 27, 772-781.
72. Wen, R., Cole, G.A., Surman, S., Blackman, M.A. & Woodland, D.L. (1996), Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J. Exp. Med., 183, 1083-1092.